$20.00 USD

Mushrooms and Antidepressants: Evidence Updates and Practical Approaches

For many years it was popularly believed that combinations of psilocybin and antidepressants were toxic. As clinical trials proceed and more persons in the public use mushrooms with therapeutic intention, there is accumulating information on the drug interaction potential between psilocybin and antidepressants (SSRIs, SNRIs).

Emerging data supports that antidepressants are non-toxic in combination with psilocybin.  Additionally, psychedelic responses to psilocybin ingestion among antidepressant users appears to range from fully sensitive to severely diminished effects.

It begs the question: How can antidepressant users understand if they 'must' taper antidepressants to use psilocybin successfully?

Practical approaches may be useful in aiding decision making about whether persons ‘must’ taper antidepressants to successfully use psilocybin or whether it could be compatible for them. This workshop will review recent data with a focus on combinations of antidepressants and psilocybin as well as hypothesize practical approaches individuals may elect to employ to better gauge and understand their sensitivity to psilocybin while using antidepressants.

Registration includes access to webpage with recording of workshop as well as downloadable copies of workshop slides and psilocybin dose testing sensitivity protocol.


This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.

There will be no refunds issued for this purchase. Registration will trigger emails that have the workshop attendance link. You will also go directly to the workshop page upon purchasing. It is your responsibility to save this link or follow up in the case you are not able to find or access it at [email protected]